Nektar Therapeutics Reports Third Quarter 2022 Financial Results

Go back to Nektar Therapeutics Reports Third Quarter 2022 Financial Results
Nektar Therapeutics (NASDAQ: NKTR) Delayed: 74.02 -0.51 (0.68%)
Previous Close $74.53    52 Week High $19.98 
Open $75.10    52 Week Low $10.52 
Day High $76.23    P/E N/A 
Day Low $72.83    EPS $-1.45 
Volume 585,338